FDA issued a Warning Letter to Fagron, Inc on 8/29/2018 for a later inspection.
483 Fagron Feb 2009

483 Fagron Feb 2009

Marie Fadden FDA, Sandra Sejdinovic FDA, Carolyn Warren FDA$119.00 - Available Now

FDA investigators audited the Fagron - Saint Paul, MN, United States facility and issued 6 inspectional observations (via FDA 483) on 11 Feb 2009.

Product details

  • Category: Human Drugs
  • Number of Observations: 6
  • Inspection end: 11 Feb 2009
  • Location: Saint Paul, United States
  • FEI: 1000174332
Add To Cart